Literature DB >> 4814992

Lethal activity of camptothecin sodium on human lymphoma cells.

B Drewinko, E J Freireich, J A Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4814992

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

Authors:  T Andoh; K Ishii; Y Suzuki; Y Ikegami; Y Kusunoki; Y Takemoto; K Okada
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors.

Authors:  Kim A Lopez; Aaron M Tannenbaum; Marcela C Assanah; Katy Linskey; Jonathan Yun; Alayar Kangarlu; Orlando D Gil; Peter Canoll; Jeffrey N Bruce
Journal:  Cancer Res       Date:  2011-04-04       Impact factor: 12.701

3.  Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.

Authors:  Y Kawato; T Furuta; M Aonuma; M Yasuoka; T Yokokura; K Matsumoto
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Clinical studies of irinotecan alone and in combination with cisplatin.

Authors:  M Fukuoka; N Masuda
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors:  C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Cross-Kingdom Regulation of Putative miRNAs Derived from Happy Tree in Cancer Pathway: A Systems Biology Approach.

Authors:  Dinesh Kumar; Swapnil Kumar; Garima Ayachit; Shivarudrappa B Bhairappanavar; Afzal Ansari; Priyanka Sharma; Subhash Soni; Jayashankar Das
Journal:  Int J Mol Sci       Date:  2017-06-03       Impact factor: 5.923

7.  Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.

Authors:  K Tamura; M Takada; I Kawase; T Tada; S Kudoh; K Okishio; M Fukuoka; N Yamaoka; Y Fujiwara; M Yamakido
Journal:  Jpn J Cancer Res       Date:  1997-02

8.  A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38.

Authors:  Y Sasaki; H Hakusui; S Mizuno; M Morita; T Miya; K Eguchi; T Shinkai; T Tamura; Y Ohe; N Saijo
Journal:  Jpn J Cancer Res       Date:  1995-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.